Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT "VERITON-CT ™" Camera (OSS)
Bone Metastases
About this trial
This is an interventional diagnostic trial for Bone Metastases focused on measuring Bone scan, solid state gama camera CZT-based detector, hybrid SPECT/CT imaging, bone metastasis
Eligibility Criteria
Inclusion Criteria:
- Patient having read and understood the information document and having signed the consent.
- Patient referred for bone scintigraphy to detect possible metastatic or primary neoplastic lesions (known neoplastic antecedent), or for assessment and / or follow-up of known neoplastic bone lesions
- Patient acceptant de réaliser les 25 minutes d'enregistrement supplémentaire avec la caméra VERITON-CT™.
- Patient being affiliated to a social security scheme
Exclusion Criteria:
- A woman who is pregnant or of childbearing age and without suitable contraceptive means
- No signature of the informed consent form by the patient.
- Unstable medical condition and / or inability to remain still in the supine position during the recordings
- Person with a known allergy to one of the components of the radiotracer (TECHNESCAN HDP).
- Person deprived of liberty by a judicial or administrative decision.
- Major person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
- Major person unable to express consent.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
group 1 in pair week
group 2 in odd week
In pair week, patients will inclued in group1: the conventional recording followed by complementary images SPECT/CT, will be realized in first intention and the procedure of recording in camera VERITON will be recorderd in second intention
in odd week, patients will inclued in group2: the procedure of recording of 25 minutes in camera VERITON-CT ™, will be realized in first intention and the procedure of conventional recording followed by complementary images SPECT/CT will be recorded in second intention